Crossmark Global Holdings, Inc. Amphastar Pharmaceuticals, Inc. Transaction History
Crossmark Global Holdings, Inc.
- $5.23 Billion
- Q2 2024
A detailed history of Crossmark Global Holdings, Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 11,300 shares of AMPH stock, worth $527,936. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,300
Previous 11,025
2.49%
Holding current value
$527,936
Previous $484,000
6.61%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
34.3MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$278 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$125 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$90.9 Million0.19% of portfolio
-
Td Asset Management Inc1.69MShares$79 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$75.8 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.29B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...